OneOme's test validation white paper

Fill out the form to access your copy of the OneOme’s test validation white paper and to have a copy emailed to you.

The OneOme RightMed® pharmacogenomic solution, co­-developed with Mayo Clinic, analyzes a patient’s DNA to predict how he or she is likely to respond to hundreds of medications, which may lead to fewer side effects, less trial­-and­-error, and more effective prescriptions.

By filling out the form, you will get a copy of OneOme’s test validation white paper, which includes information on how OneOme validated its test by using reference samples established and defined by industry standard reference samples and independently analyzed bi­directional Sanger sequencing results.

The OneOme RightMed® pharmacogenomic solution, co­developed with Mayo Clinic, analyzes a patient’s DNA to predict how he or she is likely to respond to hundreds of medications, which may lead to fewer side effects, less trial­-and­-error, and more effective prescriptions.

By filling out the form, you will get a copy of OneOme’s test validation white paper, which includes information on how OneOme validated its test by using reference samples established and defined by industry standard reference samples and independently analyzed bi­directional Sanger sequencing results.